
Company valuation, historical trends, and peer comparisons.
According to Catalyst Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.10B. This represents a change of 52.21% compared to the average of 2.04B of the last 4 quarters.
The mean historical Enterprise Value of Catalyst Pharmaceuticals, Inc. over the last ten years is 896.37M. The current 3.10B Enterprise Value has changed 246.03% with respect to the historical average. Over the past ten years (40 quarters), CPRX's Enterprise Value was at its highest in in the March 2025 quarter at 2.37B. The Enterprise Value was at its lowest in in the June 2016 quarter at 40.12M.
Average
896.37M
Median
415.06M
Minimum
73.13M
Maximum
2.15B
Discovering the peaks and valleys of Catalyst Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 280.15%
Maximum Annual Enterprise Value = 2.15B
Minimum Annual Increase = -56.95%
Minimum Annual Enterprise Value = 73.13M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 2.15B | 9.71% |
| 2024 | 1.96B | 18.48% |
| 2023 | 1.65B | 1.49% |
| 2022 | 1.63B | 205.70% |
| 2021 | 532.64M | 147.13% |
| 2020 | 215.53M | -27.55% |
| 2019 | 297.48M | 64.81% |
| 2018 | 180.50M | -35.07% |
| 2017 | 277.99M | 280.15% |
| 2016 | 73.13M | -56.95% |
The current Enterprise Value of Catalyst Pharmaceuticals, Inc. (CPRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.92B
5-year avg
1.58B
10-year avg
896.37M
Catalyst Pharmaceuticals, Inc.’s Enterprise Value is less than Amylyx Pharmaceuticals, Inc. (3.48B), less than Axsome Therapeutics, Inc. (6.88B), less than Exelixis, Inc. (17.85B), less than Madrigal Pharmaceuticals, Inc. (10.01B), greater than Talphera, Inc. (53.11M), greater than Viking Therapeutics, Inc. (3.00B), greater than Verastem, Inc. (825.99M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 3.48B | $3.52B | |
| 6.88B | $6.98B | |
| 17.85B | $17.99B | |
| 10.01B | $9.95B | |
| 53.11M | $53.85M | |
| 3.00B | $3.42B | |
| 825.99M | $878.01M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Catalyst Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Catalyst Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Catalyst Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Catalyst Pharmaceuticals, Inc. (CPRX)?
What is the 3-year average Enterprise Value for Catalyst Pharmaceuticals, Inc. (CPRX)?
What is the 5-year average Enterprise Value for Catalyst Pharmaceuticals, Inc. (CPRX)?
How does the current Enterprise Value for Catalyst Pharmaceuticals, Inc. (CPRX) compare to its historical average?